This headline is too vague to be trusted without knowing which tablets it means. Some medicines really can increase the risk of blood clots or cardiovascular events, but many tablets do not.
For example, the FDA has a prominent warning for certain JAK-inhibitor medicines, including tofacitinib, baricitinib, and upadacitinib. These medicines have been associated with increased risks of serious heart-related events, including heart attack or stroke, as well as blood clots. The risk is particularly important in people with cardiovascular risk factors such as being a current or former smoker or having previous heart disease or blood clots. (U.S. Food and Drug Administration)
🩸 “Blood thrombots” means blood clots
A thrombus is a blood clot that forms inside a blood vessel. Depending on where it occurs, a clot can cause serious problems. An arterial clot can block blood flow to the heart and cause a heart attack; a clot elsewhere can cause a stroke or other complications. (CDC)
⚠️ Don’t stop prescribed tablets because of a viral warning
This is especially important with cardiovascular medicines. Some medicines that sound frightening in a headline are actually prescribed specifically to prevent heart attacks and blood clots. For example, aspirin and clopidogrel reduce clot formation in appropriate patients. (U.S. Food and Drug Administration)
If you give me the name of the tablets (or send a photo of the package), I can tell you:
- what the medicine is,
- whether it actually increases clot/heart-attack risk,
- who is most at risk,
- common warning symptoms, and
- whether it should be stopped or continued.
